Stock

Cogent Biosciences, Inc. COGT

Market data for COGT is refreshing — check back shortly.

All stocks Create account to unlock

Overview

COGT market data

Price History

No market bars yet for COGT. This page will populate once the next provider sweep lands.

Valuation & Profitability

no valuation data

No Valuation Data Yet

Alpha Vantage and Twelve Data both returned no valuation metrics for COGT. Check back after the next daily valuation refresh — this symbol may be new, delisted, or temporarily unavailable from both providers.

Company news

5 captured

Cogent Biosciences Files New Drug Application To FDA For Bezuclastinib In Advanced Systemic Mastocytosis · Jun 30, 2026, 12:10 PM

Cogent Biosciences To Present Preclinical Data From Its Novel JAK2 V617F Mutant-Selective Inhibitor At The 2026 European Hematology Association Congress, June 11-14 · Jun 12, 2026, 12:05 PM

Wedbush Reiterates Outperform on Cogent Biosciences, Maintains $55 Price Target · May 29, 2026, 1:45 PM

Cogent Biosciences Says FDA Accepts NDA For Bezuclastinib In Combination With Sunitinib For Patients With GIST With PDUFA Target Action Date Of November 30 · May 28, 2026, 12:25 PM

8-K filing — Cogent Biosciences, Inc. (COGT) · May 5, 2026, 12:08 PM

Decision & Score

Members

Our Tradable / Watch / Avoid decision and 0–100 conviction score for this symbol are members-only.

Create account to unlock

Trend & Pattern Evidence

Members

Trend alignment and backtested chart-pattern probabilities are members-only.

Create account to unlock

Sector Peer Ranking

Members

Ranked sector peers with scores and decisions are members-only.

Create account to unlock